Antacid medicines help to improve mental health and physical health in children and adults.
The study of the efficacy of these medicines has found significant improvement in the physical and cognitive performance of children.
The most significant improvement was seen in children aged between one and five years, and there was also a significant improvement among adults.
The study by Dr. Sanjay Kumar and colleagues at the National Institute of Child Health and Medical Sciences of India, published in the journal Lancet Pediatrics, looked at the effects of four different antacid medicines for children.
Among the four medicines, it found that epinephrine, metoclopramide, ephedrine and epoxide were found to be the most effective in reducing the symptoms of ADHD.
The authors said that children aged two to five years had a reduction of symptoms of depression, anxiety, insomnia and social anxiety, as compared to children aged five to eight years.
The researchers added that the improvement in mental health, physical and physical performance was most significant in children.
The findings may have been related to the fact that these medicines work by acting on the brain receptors of the neurotransmitter serotonin, which has been identified as a key component of the brain’s reward system.
The findings are in line with earlier studies in children, where serotonin levels have been found to decrease in the brains of those with ADHD, the researchers said.
Dr. Kumar, who is also a professor at the Institute of Pharmaceutical Sciences at the University of Cambridge, said the study showed that children who are taking these medicines are also at risk for developing depression and anxiety.
He said, “The idea that you would increase your serotonin levels by taking these drugs is just nonsense, it is just a myth.
It is just that they are effective and the drug works on the neurotransmitters.
The drugs don’t actually increase serotonin.
They only reduce the activity of these neurotransmitter receptors.”
The study also showed that patients with ADHD are more likely to use the medications than those who are not taking them.
Dr Kumar said that the drugs could be of use to parents and caregivers, who would benefit from having a better understanding of the effects on the children.
“If you can understand how these medicines affect the brain and how these drugs work, then you can be more prepared to support children with ADHD.”
Dr. Kishore Jain, professor of pharmacology at the Medical College of India (MCI), who was not involved in the study, said that his team has already started working on ways to develop more effective medicines for ADHD.
“Our primary objective is to develop drugs that are effective in treating ADHD, and that will help the children who have ADHD, particularly the children in rural areas.
We are also trying to develop medicines that would be safe for children and parents.
We have started to develop compounds that would increase serotonin levels in the brain.”
He added, “These drugs could also be of interest to paediatricians.”